Real World Effectiveness, Safety and Pharmacokinetics of Switching Intravenous Vedolizumab Maintenance treatment to Subcutaneous Vedolizumab Therapy for Inflammatory Bowel Disease

被引：0

作者：

Volkers, A. ^{[1
]}

Straatmijer, T. ^{[1
]}

Duijvestein, M. ^{[2
]}

Sales, A. ^{[1
]}

Levran, A. ^{[1
]}

van Schaik, F. ^{[3
]}

Jeroen, M. ^{[4
]}

Gecse, K. ^{[1
]}

Ponsioen, C. ^{[1
]}

Grootjans, J. ^{[1
]}

Hanzel, J. ^{[1
]}

Tack, G. ^{[5
]}

Jansen, J. ^{[6
]}

Hoentjen, F. ^{[7
]}

de Boer, N. ^{[1
]}

van der Marel, S. ^{[8
]}

Dijkstra, G. ^{[9
]}

Oldenburg, B. ^{[3
]}

Lowenberg, M. ^{[1
]}

van der Meulen, A. ^{[4
]}

D'Haens, G. ^{[1
]}

机构：

[1] Amsterdam UMC, Locat AMC, Dept Gastroenterol & Hepatol, Amsterdam, Netherlands

[2] Radboud Univ Nijmegen, Med Ctr, Dept Gastroenterol & Hepatol, Nijmegen, Netherlands

[3] Univ Med Ctr Utrecht, Dept Gastroenterol & Hepatol, Utrecht, Netherlands

[4] Leiden Univ, Med Ctr, Dept Gastroenterol & Hepatol, Leiden, Netherlands

[5] Med Ctr Leeuwarden, Dept Gastroenterol & Hepatol, Leeuwarden, Netherlands

[6] Onze Lieve Vrouw Hosp, Dept Gastroenterol & Hepatol, Amsterdam, Netherlands

[7] Univ Alberta, Dept Med, Div Gastroenterol, Edmonton, AB, Canada

[8] Haaglanden Med Ctr, Dept Gastroenterol & Hepatol, Amsterdam, Netherlands

[9] Univ Med Ctr Groningen, Dept Gastroenterol & Hepatol, Groningen, Netherlands

来源：

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

DOP63

引用

页码：I108 / I109

页数：3